UCLA scientists have unlocked an important mechanism that allows chemotherapy-carrying nanoparticles — extremely small objects between 1 and 100 nanometers (a billionth of a meter) — to directly access pancreatic cancer tumors, thereby improving the ability to kill cancer cells and hence leading to more effective treatment outcome of the disease.
The researchers also confirmed the key role of a peptide (an extremely small protein) in regulating vascular access of the nanoparticle to the cancer site. Read more . . .